Abstract
The present work provides the first information concerning the immunostimulatory activity of trout recombinant interleukin-1 beta (rIL-1beta) in vivo. The predicted rainbow trout mature IL-1beta peptide was produced as a recombinant protein in Escherichia coli. Optimal migration of peritoneal leucocytes and rIL-1beta induced phagocytosis occurred following intraperitoneal injection of 1 microg of the recombinant protein. Moreover, systemic IL-1beta, COX-2 and lysozyme II gene expression was enhanced following >or=1 microg rIL-1beta administration. Finally, resistance to Aeromonas salmonicida, the causative agent of furunculosis, was augmented at early times (2 days) post-injection of 1 microg rIL-1beta.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adjuvants, Immunologic / pharmacology*
-
Aeromonas / immunology*
-
Animals
-
Cyclooxygenase 2
-
Dose-Response Relationship, Drug
-
Gram-Negative Bacterial Infections / immunology*
-
Immune System / drug effects*
-
Interleukin-1 / biosynthesis
-
Interleukin-1 / genetics
-
Interleukin-1 / pharmacology*
-
Isoenzymes / biosynthesis
-
Isoenzymes / genetics
-
Leukocyte Count
-
Leukocytes / drug effects
-
Muramidase / biosynthesis
-
Muramidase / genetics
-
Oncorhynchus mykiss / immunology*
-
Oncorhynchus mykiss / microbiology
-
Phagocytosis / drug effects
-
Prostaglandin-Endoperoxide Synthases / biosynthesis
-
Prostaglandin-Endoperoxide Synthases / genetics
Substances
-
Adjuvants, Immunologic
-
Interleukin-1
-
Isoenzymes
-
Cyclooxygenase 2
-
Prostaglandin-Endoperoxide Synthases
-
Muramidase